Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

about

Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

Item

http://www.wikidata.org/entity/Q50066074

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

@en

Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

@nl

type

Item

label

Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

@en

Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

@nl

prefLabel

Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

@en

Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

@nl

P1476

Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

@en

P2093

Anandan Palani

http://www.w3.org/2001/XMLSchema#string

Dmitri A Pissarnitski

http://www.w3.org/2001/XMLSchema#string

Eric M Parker

http://www.w3.org/2001/XMLSchema#string

Giuseppe Terracina

http://www.w3.org/2001/XMLSchema#string

Lili Zhang

http://www.w3.org/2001/XMLSchema#string

Lixin Song

http://www.w3.org/2001/XMLSchema#string

Lynn A Hyde

http://www.w3.org/2001/XMLSchema#string

William J Greenlee

http://www.w3.org/2001/XMLSchema#string

Xianhai Huang

http://www.w3.org/2001/XMLSchema#string

Zhaoning Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases

Targeting the β secretase BACE1 for Alzheimer's disease therapy.

Amyloid-beta: a crucial factor in Alzheimer's disease.

Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.

Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?

Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.

Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils

Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.

γ-Secretase modulator in Alzheimer's disease: shifting the end.

P304

1002-1006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.7B00178

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29057041

http://www.w3.org/2001/XMLSchema#string

P932

5641957

http://www.w3.org/2001/XMLSchema#string